Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication

A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the begi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2009-08, Vol.119 (8), p.1491-1494
Hauptverfasser: Iwai, Hiroshi, Nakamichi, Naoto, Nakae, Kaori, Konishi, Masaya, Inaba, Muneo, Hoshino, Shoichi, Baba, Susumu, Amakawa, Ryuichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1494
container_issue 8
container_start_page 1491
container_title The Laryngoscope
container_volume 119
creator Iwai, Hiroshi
Nakamichi, Naoto
Nakae, Kaori
Konishi, Masaya
Inaba, Muneo
Hoshino, Shoichi
Baba, Susumu
Amakawa, Ryuichi
description A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009
doi_str_mv 10.1002/lary.20258
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67535073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67535073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4618-a2a910a0d60786547a28f6109df30cc92d64b1d4be522ff81aeaba119d56d2c03</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EokvppT-gygUOSCn-iJ3kWLXQUi1QVf2AkzWxHTA468WTCPbf42VDuXEajeaZeTUPIYeMHjNK-esAaXPMKZfNI7JgUrCyalv5mCzyUJSN5J_2yDPEb5SyWkj6lOyxVtJKSrUg5gpSHL0thslEhBIQo_EwOluEzbD-GvNo9IiTm_sBiuS-JIfo46qAfnSpuHDBm9iB2TbrTYjJFy6B9QbGTD0nT3oI6A7muk9u3765Ob0olx_P352eLEtTKdaUwKFlFKhVtG6UrGrgTa8YbW0vqDEtt6rqmK06Jznv-4aBgw4Ya61Ulhsq9snL3d11ij8mh6MePBoXAqxcnFCrWub3a5HBVzvQpIiYXK_XyQ_ZomZUb5XqrVL9R2mGj-arUzc4-w-dHWbgxQwAGgh9gpXx-MBxVjdUiG0q23E_fXCb_0Tq5cn157_h5W7H4-h-PexA-p6_EbXU9x_O9eWZursU77m-Eb8BPNafrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67535073</pqid></control><display><type>article</type><title>Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Iwai, Hiroshi ; Nakamichi, Naoto ; Nakae, Kaori ; Konishi, Masaya ; Inaba, Muneo ; Hoshino, Shoichi ; Baba, Susumu ; Amakawa, Ryuichi</creator><creatorcontrib>Iwai, Hiroshi ; Nakamichi, Naoto ; Nakae, Kaori ; Konishi, Masaya ; Inaba, Muneo ; Hoshino, Shoichi ; Baba, Susumu ; Amakawa, Ryuichi</creatorcontrib><description>A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1002/lary.20258</identifier><identifier>PMID: 19504556</identifier><identifier>CODEN: LARYA8</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Amoxicillin - administration &amp; dosage ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Biopsy, Needle ; Clarithromycin - administration &amp; dosage ; Drug Therapy, Combination ; extragastric MALT lymphoma ; Female ; Follow-Up Studies ; Gastroscopy ; Helicobacter Infections - diagnosis ; Helicobacter Infections - drug therapy ; Helicobacter pylori ; Helicobacter pylori - drug effects ; Helicobacter pylori - isolation &amp; purification ; Hematologic and hematopoietic diseases ; Human bacterial diseases ; Humans ; Immunohistochemistry ; Infectious diseases ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, B-Cell, Marginal Zone - diagnosis ; Lymphoma, B-Cell, Marginal Zone - therapy ; Magnetic Resonance Imaging - methods ; Medical sciences ; Middle Aged ; Mucous Membrane - microbiology ; Mucous Membrane - pathology ; Neoplasm Recurrence, Local - drug therapy ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Omeprazole - administration &amp; dosage ; Otorhinolaryngology. Stomatology ; Parotid Neoplasms - diagnosis ; Parotid Neoplasms - surgery ; Radionuclide Imaging - methods ; Rare Diseases ; Risk Assessment ; serum sIL-2R antigen ; Sjögren's syndrome ; Treatment Outcome</subject><ispartof>The Laryngoscope, 2009-08, Vol.119 (8), p.1491-1494</ispartof><rights>Copyright © 2009 The American Laryngological, Rhinological, and Otological Society, Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4618-a2a910a0d60786547a28f6109df30cc92d64b1d4be522ff81aeaba119d56d2c03</citedby><cites>FETCH-LOGICAL-c4618-a2a910a0d60786547a28f6109df30cc92d64b1d4be522ff81aeaba119d56d2c03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flary.20258$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flary.20258$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21780333$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19504556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwai, Hiroshi</creatorcontrib><creatorcontrib>Nakamichi, Naoto</creatorcontrib><creatorcontrib>Nakae, Kaori</creatorcontrib><creatorcontrib>Konishi, Masaya</creatorcontrib><creatorcontrib>Inaba, Muneo</creatorcontrib><creatorcontrib>Hoshino, Shoichi</creatorcontrib><creatorcontrib>Baba, Susumu</creatorcontrib><creatorcontrib>Amakawa, Ryuichi</creatorcontrib><title>Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication</title><title>The Laryngoscope</title><addtitle>The Laryngoscope</addtitle><description>A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009</description><subject>Amoxicillin - administration &amp; dosage</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Needle</subject><subject>Clarithromycin - administration &amp; dosage</subject><subject>Drug Therapy, Combination</subject><subject>extragastric MALT lymphoma</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroscopy</subject><subject>Helicobacter Infections - diagnosis</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - drug effects</subject><subject>Helicobacter pylori - isolation &amp; purification</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Infectious diseases</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, B-Cell, Marginal Zone - diagnosis</subject><subject>Lymphoma, B-Cell, Marginal Zone - therapy</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mucous Membrane - microbiology</subject><subject>Mucous Membrane - pathology</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Omeprazole - administration &amp; dosage</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Parotid Neoplasms - diagnosis</subject><subject>Parotid Neoplasms - surgery</subject><subject>Radionuclide Imaging - methods</subject><subject>Rare Diseases</subject><subject>Risk Assessment</subject><subject>serum sIL-2R antigen</subject><subject>Sjögren's syndrome</subject><subject>Treatment Outcome</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EokvppT-gygUOSCn-iJ3kWLXQUi1QVf2AkzWxHTA468WTCPbf42VDuXEajeaZeTUPIYeMHjNK-esAaXPMKZfNI7JgUrCyalv5mCzyUJSN5J_2yDPEb5SyWkj6lOyxVtJKSrUg5gpSHL0thslEhBIQo_EwOluEzbD-GvNo9IiTm_sBiuS-JIfo46qAfnSpuHDBm9iB2TbrTYjJFy6B9QbGTD0nT3oI6A7muk9u3765Ob0olx_P352eLEtTKdaUwKFlFKhVtG6UrGrgTa8YbW0vqDEtt6rqmK06Jznv-4aBgw4Ya61Ulhsq9snL3d11ij8mh6MePBoXAqxcnFCrWub3a5HBVzvQpIiYXK_XyQ_ZomZUb5XqrVL9R2mGj-arUzc4-w-dHWbgxQwAGgh9gpXx-MBxVjdUiG0q23E_fXCb_0Tq5cn157_h5W7H4-h-PexA-p6_EbXU9x_O9eWZursU77m-Eb8BPNafrQ</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Iwai, Hiroshi</creator><creator>Nakamichi, Naoto</creator><creator>Nakae, Kaori</creator><creator>Konishi, Masaya</creator><creator>Inaba, Muneo</creator><creator>Hoshino, Shoichi</creator><creator>Baba, Susumu</creator><creator>Amakawa, Ryuichi</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200908</creationdate><title>Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication</title><author>Iwai, Hiroshi ; Nakamichi, Naoto ; Nakae, Kaori ; Konishi, Masaya ; Inaba, Muneo ; Hoshino, Shoichi ; Baba, Susumu ; Amakawa, Ryuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4618-a2a910a0d60786547a28f6109df30cc92d64b1d4be522ff81aeaba119d56d2c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amoxicillin - administration &amp; dosage</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Needle</topic><topic>Clarithromycin - administration &amp; dosage</topic><topic>Drug Therapy, Combination</topic><topic>extragastric MALT lymphoma</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroscopy</topic><topic>Helicobacter Infections - diagnosis</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - drug effects</topic><topic>Helicobacter pylori - isolation &amp; purification</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Infectious diseases</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, B-Cell, Marginal Zone - diagnosis</topic><topic>Lymphoma, B-Cell, Marginal Zone - therapy</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mucous Membrane - microbiology</topic><topic>Mucous Membrane - pathology</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Omeprazole - administration &amp; dosage</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Parotid Neoplasms - diagnosis</topic><topic>Parotid Neoplasms - surgery</topic><topic>Radionuclide Imaging - methods</topic><topic>Rare Diseases</topic><topic>Risk Assessment</topic><topic>serum sIL-2R antigen</topic><topic>Sjögren's syndrome</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwai, Hiroshi</creatorcontrib><creatorcontrib>Nakamichi, Naoto</creatorcontrib><creatorcontrib>Nakae, Kaori</creatorcontrib><creatorcontrib>Konishi, Masaya</creatorcontrib><creatorcontrib>Inaba, Muneo</creatorcontrib><creatorcontrib>Hoshino, Shoichi</creatorcontrib><creatorcontrib>Baba, Susumu</creatorcontrib><creatorcontrib>Amakawa, Ryuichi</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwai, Hiroshi</au><au>Nakamichi, Naoto</au><au>Nakae, Kaori</au><au>Konishi, Masaya</au><au>Inaba, Muneo</au><au>Hoshino, Shoichi</au><au>Baba, Susumu</au><au>Amakawa, Ryuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication</atitle><jtitle>The Laryngoscope</jtitle><addtitle>The Laryngoscope</addtitle><date>2009-08</date><risdate>2009</risdate><volume>119</volume><issue>8</issue><spage>1491</spage><epage>1494</epage><pages>1491-1494</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><coden>LARYA8</coden><abstract>A 60‐year‐old woman with Sjögren's syndrome showed recurrence of parotid mucosa‐associated lymphoid tissue (MALT) lymphoma with a simultaneous increase of serum sIL‐2R antigen levels 10 years after surgical treatment. Helicobacter pylori infection had been detected in the stomach since the beginning of the lymphoma. Although H. pylori was not detected in the recurrent parotid lymphoma, antibiotic therapy contributed not only to successful eradication of gastric H. pylori but also to disappearance of the recurrent lymphoma. Further studies on the mechanisms of occurrence of extragastric MALT lymphomas are needed to establish the treatment of extragastric MALT lymphomas. Laryngoscope, 2009</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>19504556</pmid><doi>10.1002/lary.20258</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0023-852X
ispartof The Laryngoscope, 2009-08, Vol.119 (8), p.1491-1494
issn 0023-852X
1531-4995
language eng
recordid cdi_proquest_miscellaneous_67535073
source MEDLINE; Wiley Online Library
subjects Amoxicillin - administration & dosage
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Biological and medical sciences
Biopsy, Needle
Clarithromycin - administration & dosage
Drug Therapy, Combination
extragastric MALT lymphoma
Female
Follow-Up Studies
Gastroscopy
Helicobacter Infections - diagnosis
Helicobacter Infections - drug therapy
Helicobacter pylori
Helicobacter pylori - drug effects
Helicobacter pylori - isolation & purification
Hematologic and hematopoietic diseases
Human bacterial diseases
Humans
Immunohistochemistry
Infectious diseases
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, B-Cell, Marginal Zone - diagnosis
Lymphoma, B-Cell, Marginal Zone - therapy
Magnetic Resonance Imaging - methods
Medical sciences
Middle Aged
Mucous Membrane - microbiology
Mucous Membrane - pathology
Neoplasm Recurrence, Local - drug therapy
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Omeprazole - administration & dosage
Otorhinolaryngology. Stomatology
Parotid Neoplasms - diagnosis
Parotid Neoplasms - surgery
Radionuclide Imaging - methods
Rare Diseases
Risk Assessment
serum sIL-2R antigen
Sjögren's syndrome
Treatment Outcome
title Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T21%3A42%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parotid%20mucosa-associated%20lymphoid%20tissue%20lymphoma%20regression%20after%20Helicobacter%20pylori%20eradication&rft.jtitle=The%20Laryngoscope&rft.au=Iwai,%20Hiroshi&rft.date=2009-08&rft.volume=119&rft.issue=8&rft.spage=1491&rft.epage=1494&rft.pages=1491-1494&rft.issn=0023-852X&rft.eissn=1531-4995&rft.coden=LARYA8&rft_id=info:doi/10.1002/lary.20258&rft_dat=%3Cproquest_cross%3E67535073%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67535073&rft_id=info:pmid/19504556&rfr_iscdi=true